Delivery Order SPE2DB22D3501-SPE2DB25FUE70

Award Date 1/17/25
Potential Completion Date 1/21/25
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with a ceiling value of $30,454.81, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Bridion 200 mg/2 ml vials, with a completion date of January 11, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $7,829.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product, with a completion date of August 6, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,623.83, is a delivery order for the supply of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of November 27, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, valued at $26,021.51, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a medical product, with a completion date of January 14, 2025. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,591.97 delivery order contract is for the supply of BRIDION 200 MG/2 ML VIAL 2ML, a specialty medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of BRIDION 200 MG/2 ML VIAL 2ML medical supplies. The contract has a ceiling value of $9,234.99 and an ultimate completion date of January 17, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product. The $4,881.85 firm-fixed-price delivery order has a completion date of July 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure a comprehensive range of medical commodities...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of BRIDION 500 MG/5 ML VIAL 5ML, a critical medication. The $10,291.34 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of August 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product, with a ceiling value of $3,474.57 and a completion date of December 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,947.85, is a delivery order for the supply of 4,566,670,834 units of the pharmaceutical product BRIDION 200 MG/2 ML VIAL 2ML. The contract is a firm-fixed-price agreement with an ultimate completion date of December 11, 2024. It is not designated as a set-aside contract. AmerisourceBergen...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FUE70
    Delivery Order

This federal contract award, with ID SPE2DB22D3501|SPE2DB25FUE70, was issued by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp. The contract is for the supply of Bridion 500 mg/5 ml vial, a pharmaceutical product, with a ceiling value of $24,073.63 and a period of performance through January 21, 2025.

The contract is a delivery order placed under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/18/25, 2:15 PM